Page 70 - SaxoCell Annual Report22/23
P. 70
With innovative ideas, new, interested project partners from science and industry, and the
continuation of successful projects and studies from the first funding phase, we are
meticulously and full of anticipation preparing the upcoming, second funding period and look
forward confidently to a sustainably growing network with the overarching goal of further
expanding the cell and gene therapy sector in Saxony and continuously improving the
treatment of serious diseases at the level of efficacy, tolerability and accessibility.
65
